Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 3/2009

01-05-2009 | Original Article

Effect of body fat stores on total and regional bone mineral density in perimenopausal Chinese women

Authors: Zhifeng Yu, Zhenan Zhu, Tingting Tang, Kerong Dai, Shijing Qiu

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2009

Login to get access

Abstract

Accumulation of body fat is known to be beneficial to bone mass through increased body weight. However, not all the skeleton is loaded by body weight. Therefore, we assume that fat stores would exert different effects on bone mass at different skeletal sites. In this study, 84 perimenopausal Chinese women were recruited. Using dual-energy X-ray absorptiometry, total body fat mass (TBFM), total body lean mass (TBLM), percent body fat (PBF), and total body and regional bone mineral density (BMD) were measured. Correlation analysis indicated that PBF correlated negatively with BMD at ribs and both arms (all P < 0.05). After adjusting for TBLM, PBF had a significantly negative correlation with BMD at head, ribs, both arms, and whole body (all P < 0.05). With adjustment for body weight and height, a significantly negative correlation between PBF and BMD was present, not only at ribs and arms but also at legs and whole body (all P < 0.05, except right leg, at P = 0.094). There was a significantly positive correlation between body weight and leg BMD (all P < 0.001). Body weight was positively correlated with TBFM (r 2 = 0.783, P < 0.001) and TBLM (r 2 = 0.770, P < 0.001). Based on the results, we conclude that increased body fat stores would exert a detrimental effect on BMD, but this effect is more prominent on non-weight-bearing bone. On weight-bearing bone, the detrimental effect of increased body fat could be offset or outweighed by the beneficial effect of increased body weight.
Literature
2.
go back to reference NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention D, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795CrossRef
3.
go back to reference Bates DW, Black DM, Cummings SR (2002) Clinical use of bone densitometry: clinical applications. JAMA 288:1898–1900PubMedCrossRef Bates DW, Black DM, Cummings SR (2002) Clinical use of bone densitometry: clinical applications. JAMA 288:1898–1900PubMedCrossRef
4.
go back to reference Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828PubMed Raisz LG (1988) Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818–828PubMed
5.
go back to reference Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506PubMedCrossRef Ralston SH, de Crombrugghe B (2006) Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492–2506PubMedCrossRef
6.
go back to reference Park HA, Lee JS, Kuller LH, Cauley JA (2007) Effects of weight control during the menopausal transition on bone mineral density. J Clin Endocrinol Metab 92:3809–3815PubMedCrossRef Park HA, Lee JS, Kuller LH, Cauley JA (2007) Effects of weight control during the menopausal transition on bone mineral density. J Clin Endocrinol Metab 92:3809–3815PubMedCrossRef
7.
go back to reference Wang MC, Bachrach LK, Van Loan M, Hudes M, Flegal KM, Crawford PB (2005) The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone (NY) 37:474–481 Wang MC, Bachrach LK, Van Loan M, Hudes M, Flegal KM, Crawford PB (2005) The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone (NY) 37:474–481
8.
go back to reference Liu JM, Zhao HY, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Chen JL (2004) Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women. Osteoporos Int 15:238–242PubMedCrossRef Liu JM, Zhao HY, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Chen JL (2004) Relationship between body composition and bone mineral density in healthy young and premenopausal Chinese women. Osteoporos Int 15:238–242PubMedCrossRef
9.
go back to reference Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM, Dawson-Hughes B (2003) Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73:27–32PubMedCrossRef Blum M, Harris SS, Must A, Naumova EN, Phillips SM, Rand WM, Dawson-Hughes B (2003) Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int 73:27–32PubMedCrossRef
10.
go back to reference Coin A, Sergi G, Beninca P, Lupoli L, Cinti G, Ferrara L, Benedetti G, Tomasi G, Pisent C, Enzi G (2000) Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int 11:1043–1050PubMedCrossRef Coin A, Sergi G, Beninca P, Lupoli L, Cinti G, Ferrara L, Benedetti G, Tomasi G, Pisent C, Enzi G (2000) Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int 11:1043–1050PubMedCrossRef
11.
go back to reference Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:1622–1627PubMedCrossRef Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C (1999) Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group. J Bone Miner Res 14:1622–1627PubMedCrossRef
12.
go back to reference Frost HM (1997) Obesity, and bone strength and “mass”: a tutorial based on insights from a new paradigm. Bone (NY) 21:211–214 Frost HM (1997) Obesity, and bone strength and “mass”: a tutorial based on insights from a new paradigm. Bone (NY) 21:211–214
13.
go back to reference Reid IR (2002) Relationships among body mass, its components, and bone. Bone (NY) 31:547–555 Reid IR (2002) Relationships among body mass, its components, and bone. Bone (NY) 31:547–555
14.
go back to reference Skerry TM, Suva LJ (2003) Investigation of the regulation of bone mass by mechanical loading: from quantitative cytochemistry to gene array. Cell Biochem Funct 21:223–229PubMedCrossRef Skerry TM, Suva LJ (2003) Investigation of the regulation of bone mass by mechanical loading: from quantitative cytochemistry to gene array. Cell Biochem Funct 21:223–229PubMedCrossRef
15.
go back to reference Chen Z, Lohman TG, Stini WA, Ritenbaugh C, Aickin M (1997) Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res 12:144–151PubMedCrossRef Chen Z, Lohman TG, Stini WA, Ritenbaugh C, Aickin M (1997) Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res 12:144–151PubMedCrossRef
16.
go back to reference Hsu YH, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, Laird N, Brain JD, Cummings SR, Bouxsein ML, Rosen CJ, Xu X (2006) Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 83:146–154PubMed Hsu YH, Venners SA, Terwedow HA, Feng Y, Niu T, Li Z, Laird N, Brain JD, Cummings SR, Bouxsein ML, Rosen CJ, Xu X (2006) Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr 83:146–154PubMed
17.
go back to reference Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674–2682PubMedCrossRef Zhao G, Monier-Faugere MC, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue LR, Malluche HH, Fagin JA, Clemens TL (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674–2682PubMedCrossRef
18.
go back to reference Douchi T, Kuwahata R, Matsuo T, Uto H, Oki T, Nagata Y (2003) Relative contribution of lean and fat mass component to bone mineral density in males. J Bone Miner Metab 21:17–21PubMedCrossRef Douchi T, Kuwahata R, Matsuo T, Uto H, Oki T, Nagata Y (2003) Relative contribution of lean and fat mass component to bone mineral density in males. J Bone Miner Metab 21:17–21PubMedCrossRef
19.
go back to reference Reid IR, Plank LD, Evans MC (1992) Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779–782PubMedCrossRef Reid IR, Plank LD, Evans MC (1992) Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779–782PubMedCrossRef
20.
go back to reference Arimatsu M, Kitano T, Kitano N, Inomoto T, Shono M, Futatsuka M (2005) Correlation between forearm bone mineral density and bone composition in Japanese females aged 18–40 years. Environ Health Prev Med 10:144–149CrossRef Arimatsu M, Kitano T, Kitano N, Inomoto T, Shono M, Futatsuka M (2005) Correlation between forearm bone mineral density and bone composition in Japanese females aged 18–40 years. Environ Health Prev Med 10:144–149CrossRef
21.
go back to reference Weiler HA, Janzen L, Green K, Grabowski J, Seshia MM, Yuen KC (2000) Percent body fat and bone mass in healthy Canadian females 10 to 19 years of age. Bone (NY) 27:203–207 Weiler HA, Janzen L, Green K, Grabowski J, Seshia MM, Yuen KC (2000) Percent body fat and bone mass in healthy Canadian females 10 to 19 years of age. Bone (NY) 27:203–207
22.
go back to reference Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640–1646PubMedCrossRef Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640–1646PubMedCrossRef
23.
go back to reference Li S, Wagner R, Holm K, Lehotsky J, Zinaman MJ (2004) Relationship between soft tissue body composition and bone mass in perimenopausal women. Maturitas 47:99–105PubMedCrossRef Li S, Wagner R, Holm K, Lehotsky J, Zinaman MJ (2004) Relationship between soft tissue body composition and bone mass in perimenopausal women. Maturitas 47:99–105PubMedCrossRef
24.
go back to reference Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA (1995) Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 10:1762–1768PubMedCrossRef Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA (1995) Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 10:1762–1768PubMedCrossRef
25.
go back to reference Prior JC (1998) Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 19:397–428PubMedCrossRef Prior JC (1998) Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 19:397–428PubMedCrossRef
26.
go back to reference Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257–275PubMedCrossRef Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257–275PubMedCrossRef
27.
go back to reference Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E (1995) The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 172:896–900PubMedCrossRef Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E (1995) The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 172:896–900PubMedCrossRef
28.
go back to reference Svendsen OL, Hassager C, Christiansen C (1995) Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 44:369–373PubMedCrossRef Svendsen OL, Hassager C, Christiansen C (1995) Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 44:369–373PubMedCrossRef
29.
go back to reference Bergstrom I, Freyschuss B, Landgren BM (2005) Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int 16:823–828PubMedCrossRef Bergstrom I, Freyschuss B, Landgren BM (2005) Physical training and hormone replacement therapy reduce the decrease in bone mineral density in perimenopausal women: a pilot study. Osteoporos Int 16:823–828PubMedCrossRef
30.
go back to reference Blake GM, Herd RJ, Patel R, Fogelman I (2000) The effect of weight change on total body dual-energy X-ray absorptiometry: results from a clinical trial. Osteoporos Int 11:832–839PubMedCrossRef Blake GM, Herd RJ, Patel R, Fogelman I (2000) The effect of weight change on total body dual-energy X-ray absorptiometry: results from a clinical trial. Osteoporos Int 11:832–839PubMedCrossRef
31.
go back to reference Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–1123PubMedCrossRef Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–1123PubMedCrossRef
32.
go back to reference Young N, Formica C, Szmukler G, Seeman E (1994) Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effects of exercise, hypogonadism, and body weight. J Clin Endocrinol Metab 78:449–454PubMedCrossRef Young N, Formica C, Szmukler G, Seeman E (1994) Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effects of exercise, hypogonadism, and body weight. J Clin Endocrinol Metab 78:449–454PubMedCrossRef
33.
go back to reference Heinonen A, Kannus P, Sievanen H, Oja P, Pasanen M, Rinne M, Uusi-Rasi K, Vuori I (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347PubMedCrossRef Heinonen A, Kannus P, Sievanen H, Oja P, Pasanen M, Rinne M, Uusi-Rasi K, Vuori I (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347PubMedCrossRef
34.
go back to reference Forsmo S, Aaen J, Schei B, Langhammer A (2006) What is the influence of weight change on forearm bone mineral density in peri- and postmenopausal women? The health study of Nord-Trondelag, Norway. Am J Epidemiol 164:890–897PubMedCrossRef Forsmo S, Aaen J, Schei B, Langhammer A (2006) What is the influence of weight change on forearm bone mineral density in peri- and postmenopausal women? The health study of Nord-Trondelag, Norway. Am J Epidemiol 164:890–897PubMedCrossRef
35.
go back to reference De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJIII, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef De Laet C, Kanis JA, Oden A, Johanson H, Johnell O, Delmas P, Eisman JA, Kroger H, Fujiwara S, Garnero P, McCloskey EV, Mellstrom D, Melton LJIII, Meunier PJ, Pols HA, Reeve J, Silman A, Tenenhouse A (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef
36.
go back to reference Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12:519–528PubMedCrossRef
37.
go back to reference Pruzansky ME, Turano M, Luckey M, Senie R (1989) Low body weight as a risk factor for hip fracture in both black and white women. J Orthop Res 7:192–197PubMedCrossRef Pruzansky ME, Turano M, Luckey M, Senie R (1989) Low body weight as a risk factor for hip fracture in both black and white women. J Orthop Res 7:192–197PubMedCrossRef
38.
go back to reference Roy DK, O’Neill TW, Finn JD, Lunt M, Silman AJ et al (2003) Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 14:19–26PubMedCrossRef Roy DK, O’Neill TW, Finn JD, Lunt M, Silman AJ et al (2003) Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 14:19–26PubMedCrossRef
39.
go back to reference Rocher E, Chappard C, Jaffre C, Benhamou CL, Courteix D (2008) Bone mineral density in prepubertal obese and control children: relation to body weight, lean mass, and fat mass. J Bone Miner Metab 26:73–78PubMedCrossRef Rocher E, Chappard C, Jaffre C, Benhamou CL, Courteix D (2008) Bone mineral density in prepubertal obese and control children: relation to body weight, lean mass, and fat mass. J Bone Miner Metab 26:73–78PubMedCrossRef
40.
go back to reference Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35–43PubMedCrossRef Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35–43PubMedCrossRef
41.
go back to reference Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29PubMedCrossRef Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29PubMedCrossRef
43.
go back to reference Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, Kassem M (2007) Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res 22:1720–1731PubMedCrossRef Qiu W, Andersen TE, Bollerslev J, Mandrup S, Abdallah BM, Kassem M (2007) Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J Bone Miner Res 22:1720–1731PubMedCrossRef
44.
go back to reference Schnitzler CM, Mesquita J (1998) Bone marrow composition and bone microarchitecture and turnover in blacks and whites. J Bone Miner Res 13:1300–1307PubMedCrossRef Schnitzler CM, Mesquita J (1998) Bone marrow composition and bone microarchitecture and turnover in blacks and whites. J Bone Miner Res 13:1300–1307PubMedCrossRef
45.
go back to reference Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207PubMedCrossRef Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207PubMedCrossRef
46.
go back to reference Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, Reszka AA (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 11(suppl 1):S108–S118PubMedCrossRef Luegmayr E, Glantschnig H, Wesolowski GA, Gentile MA, Fisher JE, Rodan GA, Reszka AA (2004) Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 11(suppl 1):S108–S118PubMedCrossRef
47.
go back to reference Tintut Y, Morony S, Demer LL (2004) Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24:e6–e10PubMedCrossRef Tintut Y, Morony S, Demer LL (2004) Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo. Arterioscler Thromb Vasc Biol 24:e6–e10PubMedCrossRef
48.
go back to reference Rico H, Arribas I, Casanova FJ, Duce AM, Hernandez ER, Cortes-Prieto J (2002) Bone mass, bone metabolism, gonadal status and body mass index. Osteoporos Int 13:379–387PubMedCrossRef Rico H, Arribas I, Casanova FJ, Duce AM, Hernandez ER, Cortes-Prieto J (2002) Bone mass, bone metabolism, gonadal status and body mass index. Osteoporos Int 13:379–387PubMedCrossRef
49.
go back to reference Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225–230PubMedCrossRef Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225–230PubMedCrossRef
Metadata
Title
Effect of body fat stores on total and regional bone mineral density in perimenopausal Chinese women
Authors
Zhifeng Yu
Zhenan Zhu
Tingting Tang
Kerong Dai
Shijing Qiu
Publication date
01-05-2009
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2009
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-009-0036-z

Other articles of this Issue 3/2009

Journal of Bone and Mineral Metabolism 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.